May 3 (Reuters) - Brickell Biotech Inc BBI.O :
- BRICKELL BIOTECH ANNOUNCES SALE OF SOFPIRONIUM BROMIDE TO BOTANIX PHARMACEUTICALS
- BRICKELL BIOTECH INC - BOTANIX HAS ACQUIRED FROM BRICKELL ALL ASSETS PRIMARILY RELATED TO SOFPIRONIUM BROMIDE
- BRICKELL BIOTECH INC - BRICKELL WILL RECEIVE UPFRONT AND POTENTIAL NEAR-TERM REGULATORY MILESTONE PAYMENTS OVER NEXT 18 MONTHS OF UP TO $9 MILLION
- BRICKELL BIOTECH INC - BRICKELL ALSO IS ELIGIBLE TO RECEIVE ADDITIONAL SUCCESS-BASED REGULATORY AND SALES MILESTONE PAYMENTS OF UP TO $168 MILLION
- BRICKELL BIOTECH INC - BOTANIX WILL BE RESPONSIBLE FOR ALL FURTHER RESEARCH, DEVELOPMENT, AND COMMERCIALIZATION OF SOFPIRONIUM BROMIDE GLOBALLY
News: BOT Brickell Biotech Announces Sale Of Sofpironium Bromide To Botanix Pharmaceuticals
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $737.5M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 40.0¢ | $3.466M | 8.500M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 82195 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 301931 | 9 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |